ArticleFrontiers in psychiatry2026
Case Report: Right-sided vagus nerve stimulation for treatment-resistant affective disorders with complex cardiac comorbidity.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vagus nerve stimulation (VNS) is a well-established treatment option for treatment-resistant affective disorders. Due to potential concerns about increased cardiac innervation on the right side, devices are almost exclusively implanted on the left cervical vagus nerve. Clinical data on right-sided VNS for psychiatric indications are often very scarce. Methods: We present a case series involving three patients-two with MDD and one with bipolar depression-each with extensive prior unsuccessful treatments, frequent hospitalizations, and severe psychiatric and medical comorbidities. In each case, the right cervical side was chosen for primary implantation or re-implantation due to cardiac disease, pre-existing devices, or anatomical constraints (including high-grade atrioventricular block with pacemaker and recurrent laryngeal nerve palsy). All patients underwent standard titration of stimulation parameters and long-term clinical follow-up. Results: All three patients showed significant and lasting mood stabilization within approximately 12 months after right-sided VNS implantation. Hospital admission rates decreased markedly, and in two cases, maintenance electroconvulsive therapy (ECT) was discontinued or notably reduced. In all cases, VNS was generally well tolerated. During right-sided stimulation, no clinically significant bradyarrhythmia, device interactions, or other serious cardiac adverse events were observed. Conclusions: This series highlights the usefulness of right-sided VNS in sustaining long-term mood stability and reducing hospitalizations for patients with highly treatment-resistant, comorbid mood disorders. The findings expand existing epilepsy-focused data on right-sided VNS to the psychiatric field and support systematic evaluation of this approach in future prospective studies. Multidisciplinary coordination is essential to minimize risks and improve outcomes. Additional long-term research is needed to assess its lasting effectiveness, optimal candidate selection, and cost-efficiency in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.